The third installment of the Columbia Precision Medicine Initiative Life Science Entrepreneurship seminar series, features a discussion with Kevin Mills, PhD (CSO, Cyteir Therapeutics), Laurence Blumberg, MD (COO, Syntimmune), and Jerry Kokoshka, PhD (Senior Associate Directory, CTV). The panel, moderated by Tig Conger, MBA (Columbia Business School), offer personal pitfalls, success stories, and advice on starting a pre-clinical stage company with a focus on identifying a lead program, securing funding, building a management team, and regulatory and clinical planning.
